Brief: ALX Oncology Q1 Basic EPS USD -0.17
08/05/2026 13:00
May 08 (Reuters) - ALX Oncology Q1 operating expenses USD 18.966 million. Q1 income from operations USD -18.966 million Q1 net income USD -17.927 million Q1 EPS USD -0.17
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing